US2023092332A1PendingUtilityA1
Hemostatic sponge
Est. expiryApr 7, 2030(~3.7 yrs left)· nominal 20-yr term from priority
A61F 2013/0011A61L 24/0036A61L 15/44A61L 15/325A61L 15/26A61L 24/0094A61L 2300/254A61L 2400/04A61P 17/02A61L 2300/606A61F 13/00063A61L 2300/418A61L 15/18A61L 2300/252C12Y 304/21005A61L 15/425A61L 15/32A61L 2300/232A61L 15/28A61L 15/225A61L 2420/02
75
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides a hemostatic porous composite sponge comprising i) a matrix of a biomaterial; and ii) one hydrophilic polymeric component comprising reactive groups wherein i) and ii) are associated with each other so that the reactivity of the polymeric component is retained, wherein associated means that said polymeric component is coated onto a surface of said matrix of a biomaterial, or said matrix is impregnated with said polymeric material, or both.
Claims
exact text as granted — not AI-modified1 - 10 . (canceled)
11 . A hemostatic composite comprising a hemostatic material and a single hydrophilic polymeric crosslinker, said crosslinker having electrophilic reactive groups, said composite comprising pores which allow external fluids, especially human blood, to access into said composite, wherein said hemostatic material is a non-woven or woven fabric of a hemostatic fiber.
12 . A hemostatic composite according to claim 11 , wherein said hemostatic material is a fabric of oxidized cellulose.
13 . A hemostatic composite according to claim 11 , wherein said hydrophilic polymeric crosslinker with electrophilic reactive groups is a polyethylene glycol (PEG) comprising two or more reactive groups selected from the group consisting of succinimidylesters (—CON(COCH 2 ) 2 ), aldehydes (—CHO) and isocyanates (—N═C═O).
14 . A hemostatic composite according to claim 12 , wherein said hydrophilic polymeric crosslinker with electrophilic reactive groups is a polyethylene glycol (PEG) comprising two or more reactive groups selected from the group consisting of succinimidylesters (—CON(COCH 2 ) 2 ), aldehydes (—CHO) and isocyanates (—N═C═O).
15 . A hemostatic composite according to claim 12 , wherein said hydrophilic polymeric crosslinker with electrophilic reactive groups is a polyethylene glycol (PEG) comprising two or more reactive succinimidylester (—CON(COCH 2 ) 2 ) groups.Join the waitlist — get patent alerts
Track US2023092332A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.